Patents by Inventor Bjoern Colin Kahrs

Bjoern Colin Kahrs has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHARMACEUTICAL COMPOSITIONS COMPRISING GLITAZONES AND NRF2 ACTIVATORS
    Publication number: 20230190720
    Abstract: The invention relates to pharmaceutical compositions comprising PPAR agonists and Nrf2 activators and methods of using combinations of PPAR agonists and Nrf2 activators for treating diseases such as psoriasis, asthma, multiple sclerosis, inflammatory bowel disease, and arthritis.
    Type: Application
    Filed: October 26, 2022
    Publication date: June 22, 2023
    Inventor: BJOERN COLIN KAHRS
  • Pharmaceutical compositions comprising the PPAR agonist INT-131 and Nrf2 activators
    Patent number: 11484530
    Abstract: The invention relates to pharmaceutical compositions comprising PPAR agonists and Nrf2 activators and methods of using combinations of PPAR agonists and Nrf2 activators for treating diseases such as psoriasis, asthma, multiple sclerosis, inflammatory bowel disease, and arthritis.
    Type: Grant
    Filed: August 28, 2019
    Date of Patent: November 1, 2022
    Inventor: Bjoern Colin Kahrs
  • PHARMACEUTICAL COMPOSITIONS COMPRISING THE PPAR AGONIST INT-131 AND NRF2 ACTIVATORS
    Publication number: 20190381023
    Abstract: The invention relates to pharmaceutical compositions comprising PPAR agonists and Nrf2 activators and methods of using combinations of PPAR agonists and Nrf2 activators for treating diseases such as psoriasis, asthma, multiple sclerosis, inflammatory bowel disease, and arthritis.
    Type: Application
    Filed: August 28, 2019
    Publication date: December 19, 2019
    Inventor: BJOERN COLIN KAHRS
  • Pharmaceutical compositions comprising glitazones and NRF2 activators
    Patent number: 10426763
    Abstract: The invention relates to pharmaceutical compositions comprising PPAR agonists and Nrf2 activators and methods of using combinations of PPAR agonists and Nrf2 activators for treating diseases such as psoriasis, asthma, multiple sclerosis, inflammatory bowel disease, and arthritis.
    Type: Grant
    Filed: November 21, 2016
    Date of Patent: October 1, 2019
    Inventor: Bjoern Colin Kahrs
  • PHARMACEUTICAL COMPOSITIONS COMPRISING GLITAZONES AND NRF2 ACTIVATORS
    Publication number: 20170065571
    Abstract: The invention relates to pharmaceutical compositions comprising PPAR agonists and Nrf2 activators and methods of using combinations of PPAR agonists and Nrf2 activators for treating diseases such as psoriasis, asthma, multiple sclerosis, inflammatory bowel disease, and arthritis.
    Type: Application
    Filed: November 21, 2016
    Publication date: March 9, 2017
    Inventor: BJOERN COLIN KAHRS
  • Pharmaceutical compositions comprising glitazones and Nrf2 activators
    Patent number: 9504679
    Abstract: The invention relates to pharmaceutical compositions comprising PPAR agonists and Nrf2 activators and methods of using combinations of PPAR agonists and Nrf2 activators for treating diseases such as psoriasis, asthma, multiple sclerosis, inflammatory bowel disease, and arthritis.
    Type: Grant
    Filed: December 10, 2012
    Date of Patent: November 29, 2016
    Inventor: Bjoern Colin Kahrs
  • PHARMACEUTICAL COMPOSITIONS COMPRISING GLITAZONES AND NRF2 ACTIVATORS
    Publication number: 20150133507
    Abstract: The invention relates to pharmaceutical compositions comprising PPAR agonists and Nrf2 activators and methods of using combinations of PPAR agonists and Nrf2 activators for treating diseases such as psoriasis, asthma, multiple sclerosis, inflammatory bowel disease, and arthritis.
    Type: Application
    Filed: December 10, 2012
    Publication date: May 14, 2015
    Applicant: ARES TRADING S.A.
    Inventor: Bjoern Colin Kahrs